Mannatech's Disclosure Policy
There is a skeptical conclusion about Mannatech's new policy over at Quatloos, no doubt instituted in response to the recent controvery, Quatloos! :: View topic - Mannatech Institutes Policy Against Improper Health Claims
Here is the policy.
1. Associates should immediately cease the use of all materials in any form, including educational materials, that link the benefits of glyconutrients in association with any particular disease, disease process, or disease claim in conjunction with the sale of Mannatech products.2. Third party vendor literature is no longer permitted to be sold or distributed at Mannatech corporate or associate sponsored events.
3. The use of testimonials that link the benefits of Mannatech products in association with any particular disease, disease process, or disease claim will not be permitted in conjunction with the sale of Mannatech products.
4. Additional resources for Web site compliance -- Mannatech has contracted with a third-party service provider for additional support in screening potential non-compliant Web sites, issuing automated cease and desist letters, and following up with additional reviews of offending Web sites. Mannatech is expanding its internal compliance department with the addition of five full-time employees who will provide in-house services supporting these initiatives.
"These initiatives are the result of an ongoing review of the Company's compliance policies and reinforce the Company's tone at the top," said Gerald Gilbert, chairman of the Compliance Committee of the Board of Directors.
This sounds very much like an attempt to force a settlement with the Texas AG. It will be very interesting to see how long this compliance lasts for, how it is monitored, and how long it takes for the testimonials to re-appear.
It is fairly hard to sell sugar pills for a step price, unless there is also a Jack in the Beanstalk story which accompanies the sale.
We shall see.
